Here are some of the things that makes our data unique:

1️⃣Fast access to comprehensive data
The average time to fully process applications at The Danish Health Data Authority ( […]

Certain patient groups may be underrepresented or excluded from RCTs due to eligibility criteria, logistical barriers, ethical concerns or other reasons.

Examples of these potential groups are females, pregnant or breastfeeding females, older adults due to age or comorbidities, children, people […]

Quantify Research‘s very own Mary Rosenzweig will join speakers from Monsenso, Lundbeck and […]

Data that’s not fit-for-purpose can be scary, but here’s the good news – Nordic data has many characteristics that allow it to be considered high-quality for a wide range of purposes. These […]

The landscape of healthcare research is rapidly evolving, and social media is emerging as a valuable resource for real-world evidence (RWE) studies.

In one of Quantify’s publications, 𝐒𝐨𝐜𝐢𝐚𝐥 𝐌𝐞𝐝𝐢𝐚 𝐋𝐢𝐬𝐭𝐞𝐧𝐢𝐧𝐠 𝐟𝐨𝐫 𝐑𝐞𝐚𝐥-𝐖𝐨𝐫𝐥𝐝 𝐄𝐯𝐢𝐝𝐞𝐧𝐜𝐞: 𝐀 𝐍𝐨𝐯𝐞𝐥 𝐀𝐩𝐩𝐫𝐨𝐚𝐜𝐡 𝐭𝐨 𝐇𝐞𝐚𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐏𝐚𝐭𝐢𝐞𝐧𝐭’𝐬 𝐕𝐨𝐢𝐜𝐞, […]

Literature reviews are essential throughout the pharmaceutical product development lifecycle, from identifying therapeutic targets to assisting with regulatory and health technology assessment submissions and ultimately improving drug safety and patient outcomes at every stage.

This image presents the use cases for […]

Nordic registers have been described as a goldmine for producing Real-World Evidence (RWE) in health and welfare research.
The benefits of national registers are well-known; these administrative registers provide comprehensive longitudinal individual-level data with complete coverage for the total population.
Today, we’d […]